PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 215 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $6,000 | +20.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,000 | -28.6% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $7,000 | +40.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $5,000 | -84.8% | 2,000 | -61.1% | 0.00% | -85.7% |
| Q2 2015 | $33,000 | -5.7% | 5,138 | +2.4% | 0.01% | -12.5% |
| Q1 2015 | $35,000 | -7.9% | 5,019 | +2.1% | 0.01% | -11.1% |
| Q4 2014 | $38,000 | +5.6% | 4,917 | +2.0% | 0.01% | +12.5% |
| Q3 2014 | $36,000 | -21.7% | 4,819 | +1.6% | 0.01% | -20.0% |
| Q2 2014 | $46,000 | +17.9% | 4,745 | +1.6% | 0.01% | 0.0% |
| Q1 2014 | $39,000 | 0.0% | 4,672 | +1.8% | 0.01% | 0.0% |
| Q4 2013 | $39,000 | +5.4% | 4,589 | +1.8% | 0.01% | -28.6% |
| Q3 2013 | $37,000 | +8.8% | 4,506 | +1.9% | 0.01% | +55.6% |
| Q2 2013 | $34,000 | – | 4,422 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |